A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
Posted in biotech/medical
Posted in biotech/medical
A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.